Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies

Journal of the American Medical Association

Volumn 279, Issue 18, 1998, Pages 1477-1482

  Danesh, John ^a   Collins, Rory ^a   Appleby, Paul ^b   Peto, Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FIBRINOGEN;

ACUTE PHASE RESPONSE; ALBUMIN BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW;

C-REACTIVE PROTEIN; CORONARY DISEASE; FIBRINOGEN; HUMANS; LEUKOCYTE COUNT; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN;

EID: 0032513756     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.18.1477     Document Type: Review

References (35)

1. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141-212.
2. Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994;15:74-80.
3. Rumley A, Lowe GDO, Norrie J, Ford I, Shepherd J, Cobbe SM. Blood rheology and outcome in the west of Scotland coronary prevention study. Br J Haematol. 1997;97(suppl 1):78.
4. Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC. Pibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. Eur Heart J. 1996;17:1814-1820.
5. Folsom, AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease. Circulation. 1997;96:1102-1108.
6. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. JAMA. 1987;258:1183-1186.
7. Kannel WB. Fibrinogen: a major cardiovascular risk factor. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: A "New" Cardiovascular Risk Factor. Vienna, Austria: Blackwell-MZV; 1992:101-109.
8. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
9. Eriksson H, Wilhelmsen L, Welin L, Larsson B, Svardsudd K, Tibblin G. 21-year follow-up of CVD and total mortality among men born in 1913. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: A "New" Cardiovascular Risk Factor. Vienna, Austria: Blackwell-MZV; 1992: 115-119.
10. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993; 342:1076-1079.
11. Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol. 1997;17:1539-1544.
12. Cremer P, Nagel D, Bottcher B, Seidel D. Fibrinogen: ein koronärer Risikfaktor. Diagn Labor. 1991;42:28-35.
13. Feskens EJM, Kromhout D. Fibrinogen and factor VII activity as risk factors for cardiovascular disease in an elderly cohort. Can J Cardiol. 1997;13 (suppl B):282B.
14. Stone MC, Thorp JM. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985; 35:566-569.
15. Tunstall-Pedoe H, Woodward M, Tavendale R, Brook RA, McCluskey MK. Comparison of the prediction by 27 different risk factors of coronary heart disease and death in men and women of the Scottish Heart Health Study. BMJ. 1997;315:722-729.
16. Lowe GDO, Lee AJ, Rumley A, Price JF, Fowkes FGR. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997;96:168-173.
17. Benderly M, Graff E, Reicher-Reiss H, BeharS, Brunner D, Godbourt U. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol. 1996;16:351-356.
18. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 1997;96:4204-4210.
19. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
20. Haines AP, Howarth D, North WRS, et al. Haemostatic variables and outcome of myocardial infarction. Thromb Haemostas. 1983;50:800-803.
21. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991;338:1409-1411.
22. Kostis JB, Baughman DJ, Kuo PT. Association of recurrent myocardial infarction with hemostatic factors: a prospective study. Chest. 1982;81:571-575.
23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
24. Koenig W, Froehlich F, Sund M, et al. C-reactive protein (CRP) predicts risks of coronary heart disease (CHD) in healthy middle-aged men: results from the MONICA-Augsburg cohort study, 1984/ 85-1992. Circulation. 1997;96(suppl 1):I-99.
25. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
26. Tracy R, Lemaitre R, Psaty B, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
27. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
28. Weijenberg MP, Feskens EJM, Souverijn JHM, Kromhout D. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology. 1997;8:87-92.
29. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992; 123:507-513.
30. Law MR, Morris JK, Wald NJ, Hale AK. Serum albumin and mortality in the BUPA Study. Int J Epidemiol. 1994;23:38-41.
31. Corti MC, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol. 1996;49:519-526.
32. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1991;134:1266-1277.
33. Richard JL, Warnet JM, Ducimetiere P. La baise du taux de la fraction albumine-alpha-1 globuline des proteines seriques, facteur de risque des cardiopathes ischemiques. Rev Epid Sante Publ. 1985;33:347-351.
34. Tracy R, Lemaitre R, Psaty B, Cushman M, Meilahn E, Kuller L. Relationship of C-reactive protein to risk of cardiovascular disease in the Cardiovascular Health Study. Circulation. 1997;93:622.
35. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiological Follow-up Study. Am Heart J. 1993;125:855-863.